Yi-Che Chang Chien

Dr. Yi-Che Chang Chien


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2012 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YCYi-Che Chang Chien
Yi-Che Chang Chien
PTPéter Tátrai
Péter Tátrai
GPGergő Papp
Gergő Papp
JSJohanna Sápi
Johanna Sápi
LFLászló Fónyad
László Fónyad
ZSZoltán Sápi
Zoltán Sápi
Background: Enhancer of zeste homologue 2 (EZH2) is a polycomb group (PcG) family protein. Acting as a histone methyltransferase it plays crucial roles in maintaining epigenetic stem cell signature, while its deregulation leads to tumor development. EZH2 overexpression is commonly associated with poor prognosis in a variety of tumor types including carcinomas, lymphomas and soft tissue sarcomas. However, although the synovial sarcoma fusion proteins SYT-SSX1/2/4 are known to interact with PcG members, the diagnostic and prognostic significance of EZH2 expression in synovial sarcoma has not yet been investigated. Also, literature data are equivocal on the correlation between EZH2 expression and the abundance of trimethylated histone 3 lysine 27 (H3K27me3) motifs in tumors.Methods: Immunohistochemical stains of EZH2, H3K27me3, and Ki-67 were performed on tissue microarrays containing cores from 6 poorly differentiated, 39 monophasic and 10 biphasic synovial sarcomas, and evaluated by pre-established scoring criteria. Results of the three immunostainings were compared, and differences were sought between the histological subtypes as well as patient groups defined by gender, age, tumor location, the presence of distant metastasis, and the type of fusion gene. The relationship between EZH2 expression and survival was plotted on a Kaplan-Meier curve.Results: High expression of EZH2 mRNA and protein was specifically detected in the poorly differentiated subtype. EZH2 scores were found to correlate with those of Ki-67 and H3K27me3. Cases with high EZH2 score were characterized by larger tumor size (≥ 5cm), distant metastasis, and poor prognosis. Even in the monophasic and biphasic subtypes, higher expression of EZH2 was associated with higher proliferation rate, larger tumor size, and the risk of developing distant metastasis. In these histological groups, EZH2 was superior to Ki-67 in predicting metastatic disease.Conclusions: High expression of EZH2 helps to distinguish poorly differentiated synovial sarcoma from the monophasic and biphasic subtypes, and it is associated with unfavorable clinical outcome. Importantly, high EZH2 expression is predictive of developing distant metastasis even in the better-differentiated subtypes. EZH2 overexpression in synovial sarcoma is correlated with high H3K27 trimethylation. Thus, along with other epigenetic regulators, EZH2 may be a future therapeutic target.

5 October 2011 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
THTsan-Yu Hsieh
Tsan-Yu Hsieh
YCYi-Che Chang Chien
Yi-Che Chang Chien
WCWen-Hsiang Chen
Wen-Hsiang Chen
SCSiu-Chung Chen
Siu-Chung Chen
LCLiang-Che Chang
Liang-Che Chang
JCJim-Ray Chen
Jim-Ray Chen
The kidney is a relatively infrequent site for solitary fibrous tumor (SFT). Among the previously reported cases, only two cases of malignant renal SFT developing via dedifferentiation from a pre-existing benign SFT have been reported. Here we reported a case of de novo malignant renal SFT clinically diagnosed as renal cell carcinoma in a 50-year-old woman. The tumor was circumscribed but unencapsulated and showed obvious hemorrhagic necrosis. Microscopically, the tumor was composed of patternless sheets of alternating hypercellular and hypocellular areas of spindle cells displaying mild to moderate nuclear atypia, frequent mitoses up to 8 per 10 high power fields, and a 20% Ki-67 proliferative index. Immunohistochemical studies revealed reactivity for CD34, CD99 and vimentin, with no staining for all other markers, confirming the diagnosis of SFT. No areas of dedifferentiation were seen after extensive sampling. Based on the pathologic and immunohistochemical features, a diagnosis of de novo malignant renal SFT was warranted. Our report expands the spectrum of malignant progression in renal SFTs. Even though this patient has been disease-free for 30 months, long-term follow-up is still mandatory.

1 December 2014 in Pathology - Research and Practice
Verified
Journal Article
Closed access
YCYi-Che Chang Chien
Yi-Che Chang Chien
PBPál Bocskai
Pál Bocskai
IKIlona Kovács
Ilona Kovács
ZHZoltán Hargitai
Zoltán Hargitai
SKSándor Kollár
Sándor Kollár
MTMiklós Török
Miklós Török

1 October 2012 in Pathology - Research and Practice
Verified
Journal Article
Closed access
YCYi-Che Chang Chien
Yi-Che Chang Chien
IHIrén Haltrich
Irén Haltrich
TMTamás Micsik
Tamás Micsik
EKEszter Kiss
Eszter Kiss
LFLászló Fónyad
László Fónyad
ZSZoltán Sápi
Zoltán Sápi

3 November 2011 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
ZBZsófia Balogh
Zsófia Balogh
ZSZsuzsanna Szemlaky
Zsuzsanna Szemlaky
MSMiklós Szendrői
Miklós Szendrői
IAImre Antal
Imre Antal
Zsuzsanna PápaiZsuzsanna Pápai
Zsuzsanna Pápai
ZSZoltán Sápi
Zoltán Sápi
Although synovial sarcoma is the 3rd most commonly occurring mesenchymal tumor in young adults, usually with a highly aggressive clinical course; remarkable differences can be seen regarding the clinical outcome. According to comparative genomic hybridization (CGH) data published in the literature, the simple and complex karyotypes show a correlation between the prognosis and clinical outcome. In addition, the connection between DNA ploidy and clinical course is controversial. The aim of this study was using a fine-tuning interpretation of our DNA ploidy results and to compare these with metaphase high-resolution CGH (HR-CGH) results.

31 August 2015 in Case Reports in Pathology
Verified
Journal Article
Open access
PDF file
TTTeodóra Tóth
Teodóra Tóth
YCYi-Che Chang Chien
Yi-Che Chang Chien
SKSándor Kollár
Sándor Kollár
IKIlona Kovács
Ilona Kovács
Massive localized lymphedema (MLL) is a rare pseudosarcomatous lesion due to localized lymphatic obstruction from variable causes. It is most common on medial aspect of thigh and inguinal region. Abdominal localization is rare and may cause clinical diagnostic confusion with other malignant tumors due to its large size. We report a case of abdominal wall MLL of a 56-year-old male patient under clinical suspicion of well differentiated liposarcoma. The literature search and differential diagnosis will be addressed. In doubt cases, immunohistochemical stain or fluorescent in situ hybridization can help to separate this entity from the other mimickers. Massive localized lymphedema (MLL) is a rare pseudosarcomatous lesion due to localized lymphatic obstruction from variable causes. It is most common on medial aspect of thigh and inguinal region. Abdominal localization is rare and may cause clinical diagnostic confusion with other malignant tumors due to its large size. We report a case of abdominal wall MLL of a 56-year-old male patient under clinical suspicion of well differentiated liposarcoma. The literature search and differential diagnosis will be addressed. In doubt cases, immunohistochemical stain or fluorescent in situ hybridization can help to separate this entity from the other mimickers.